GE HealthCare Technologies Inc. (GEHC) To Go Ex-Dividend on October 24th

GE HealthCare Technologies Inc. (NASDAQ:GEHC) declared a quarterly dividend on Wednesday, September 24th, RTT News reports. Investors of record on Friday, October 24th will be given a dividend of 0.035 per share on Friday, November 14th. This represents a c) annualized dividend and a yield of 0.2%. The ex-dividend date is Friday, October 24th.

GE HealthCare Technologies has a dividend payout ratio of 3.0% indicating that its dividend is sufficiently covered by earnings. Analysts expect GE HealthCare Technologies to earn $5.20 per share next year, which means the company should continue to be able to cover its $0.14 annual dividend with an expected future payout ratio of 2.7%.

GE HealthCare Technologies Price Performance

NASDAQ GEHC opened at $76.10 on Wednesday. The company has a market capitalization of $34.74 billion, a PE ratio of 15.59, a price-to-earnings-growth ratio of 2.88 and a beta of 1.13. The company has a debt-to-equity ratio of 0.85, a quick ratio of 0.93 and a current ratio of 1.16. The business’s fifty day moving average is $74.60 and its 200 day moving average is $72.16. GE HealthCare Technologies has a fifty-two week low of $57.65 and a fifty-two week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share for the quarter, beating the consensus estimate of $0.91 by $0.15. The company had revenue of $5 billion for the quarter, compared to the consensus estimate of $4.96 billion. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.GE HealthCare Technologies’s quarterly revenue was up 3.5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. Sell-side analysts predict that GE HealthCare Technologies will post 4.68 earnings per share for the current year.

Institutional Trading of GE HealthCare Technologies

Hedge funds have recently bought and sold shares of the stock. Dodge & Cox increased its position in shares of GE HealthCare Technologies by 42.1% during the second quarter. Dodge & Cox now owns 23,567,950 shares of the company’s stock worth $1,745,678,000 after purchasing an additional 6,982,441 shares in the last quarter. Norges Bank acquired a new position in shares of GE HealthCare Technologies during the second quarter worth $468,120,000. Holocene Advisors LP increased its position in shares of GE HealthCare Technologies by 178.5% during the second quarter. Holocene Advisors LP now owns 4,027,352 shares of the company’s stock worth $298,306,000 after purchasing an additional 2,581,522 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of GE HealthCare Technologies by 49.9% during the first quarter. JPMorgan Chase & Co. now owns 5,140,549 shares of the company’s stock worth $414,894,000 after purchasing an additional 1,711,963 shares in the last quarter. Finally, Menora Mivtachim Holdings LTD. acquired a new position in shares of GE HealthCare Technologies during the second quarter worth $80,755,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.